This approach previously predicted the response of glioblastoma and melanoma cell lines to both genotoxic chemotherapy (temozolomide and dacarbazine, respectively) and TRAIL-induced apoptosis [21–23]. This evidence concerns the gene TNFSF10 and glioblastoma.